NRNRx Pharmaceuticals, Inc. NRXP · NASDAQ
$2.60 -4.06% (-$0.11)
- Market cap
- $117.3M
- Enterprise value
- $91.9M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 34.6x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -1,855.5%
- Gross margin
- 32.7%
- Net margin
- -691.8%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 2.07
- Free float
- 86.4%
About the company
NRx Pharmaceuticals, Inc. (NRXP) is a pharmaceutical company focused on research and development of new drugs for the treatment of serious diseases. The company specializes in therapeutic approaches for diseases that currently lack effective treatments or have inadequate treatment options. NRx Pharmaceuticals emphasizes innovation and utilizes modern technologies and scientific knowledge to discover new treatment possibilities. Their drugs are aimed at potential treatments for diseases in areas such as neurology, oncology, infectious diseases, and more. The company is actively developing drugs and conducting clinical trials to confirm the effectiveness and safety of their products. NRx Pharmaceuticals aims to bring new drugs to the market that can make a significant improvement for patients with serious diseases. NRx Pharmaceuticals, Inc. (NRXP) shares may be an attractive investment opportunity for investors interested in the pharmaceutical sector and seeking an investment in a company focused on innovative therapeutic approaches for serious diseases.
Sector
Healthcare
Industry
Biotechnology
CEO
Jonathan C. Javitt
Employees
29
Headquarters
Wilmington
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number